Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 6/20 | 0.65 |
| ▸ | TERT | O14746 | 3/20 | 0.63 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.63 |
| ▸ | PPARG | P37231 | 3/20 | 0.63 |
| ▸ | PPARD | Q03181 | 3/20 | 0.63 |
| ▸ | PPARA | Q07869 | 3/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.63 |
| ▸ | BLM | P54132 | 2/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.63 |
| ▸ | FABP4 | P15090 | 2/20 | 0.63 |
| ▸ | FAAH | O00519 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | F7 | P08709 | 2/20 | 0.63 |
| ▸ | F3 | P13726 | 2/20 | 0.63 |
| ▸ | GMNN | O75496 | 1/20 | 0.63 |
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7045888 | 1.00 | FABP3 (0.65) | FABP3TERTPTPN1PPARGPPARD | |
| SCHEMBL1626315 | 1.00 | FABP3 (0.65) | FABP3TERTPTPN1PPARGPPARD | |
| Hydrochloric Acid SCHEMBL25963 | 0.98 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Propane SCHEMBL480215 | 0.98 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Water SCHEMBL3915284 | 0.98 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Hydrochloric Acid SCHEMBL35815 | 0.98 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Bromide SCHEMBL3414482 | 0.98 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Iodide SCHEMBL6695071 | 0.98 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Water SCHEMBL3915280 | 0.98 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD | |
| Bromide SCHEMBL28018195 | 0.98 | FABP3 (0.62) | FABP3TERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025080869-A1 | PANCREATIC CANCER IMMUNOTHERAPY USING CATIONIC LIPID AND POLYMER NANOCARRIERS FOR CO-DELIVERY OF KRAS NEOANTIGENS AND STING AND/OR OTHER IMMUNOMODULATORS TO BOOST THE CANCER IMMUNITY CYCLE AND TREAT LIVER METASTASIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-04-17 | — | — | WO | claimed |
| CN-119424690-A | Electronegativity-adjustable contrast agent film forming agent composition, contrast agent and preparation method thereof | 北京大学 | 2025-02-14 | — | — | CN | claimed |
| EP-4342929-A1 | POLYETHYLENE GLYCOL LIPID AND USE THEREOF | Jenkem Technology Co. Ltd. (Tianjin) (CN) | 2024-03-27 | — | — | EP | claimed |
| EP-2833869-B1 | METHOD OF PREPARING COMPOSITION FOR DELIVERING AN ANIONIC DRUG | SAMYANG BIOPHARMACEUTICALS (KR) | 2020-10-28 | — | — | EP | claimed |
| EP-2729124-B1 | CATIONIC OIL-IN-WATER EMULSIONS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2018-10-24 | — | — | EP | claimed |
| EP-2590625-B1 | CATIONIC OIL-IN-WATER EMULSIONS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2017-09-20 | — | — | EP | claimed |
| EP-0832271-B1 | LIPID-NUCLEIC ACID PARTICLES PREPARED VIA A HYDROPHOBIC LIPID-NUCLEIC ACID COMPLEX INTERMEDIATE AND USE FOR GENE TRANSFER | INEX PHARMACEUTICAL CORP (CA) | 2004-12-22 | — | — | EP | claimed |
| CN-120129751-A | Novel secretion signal peptide | 得克萨斯大学体系董事会 | 2025-06-10 | — | — | CN | disclosed |
| WO-2025080869-A1 | PANCREATIC CANCER IMMUNOTHERAPY USING CATIONIC LIPID AND POLYMER NANOCARRIERS FOR CO-DELIVERY OF KRAS NEOANTIGENS AND STING AND/OR OTHER IMMUNOMODULATORS TO BOOST THE CANCER IMMUNITY CYCLE AND TREAT LIVER METASTASIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-04-17 | — | — | WO | disclosed |
| CN-119424690-A | Electronegativity-adjustable contrast agent film forming agent composition, contrast agent and preparation method thereof | 北京大学 | 2025-02-14 | — | — | CN | disclosed |
| WO-2024041372-A1 | BRANCHED POLYPEPTIDE VECTOR FOR EFFECTIVELY DELIVERING NUCLEIC ACIDS AND VARIANT THEREOF | 苏州慧疗生物医药科技有限公司 | 2024-02-29 | — | — | WO | disclosed |
| US-11802144-B2 | Circular RNA compositions and methods | ORNA THERAPEUTICS, INC. (US) | 2023-10-31 | — | — | US | disclosed |
| US-20230331806-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-10-19 | — | — | US | disclosed |
| CN-107266391-A | Amine cation lipid and application thereof | 迪克纳制药公司 | 2017-10-20 | — | — | CN | disclosed |
| CN-103987847-B | amine cationic lipids and uses thereof | 迪克纳制药公司 | 2017-06-16 | — | — | CN | disclosed |
| CN-106687120-A | Plant sRNA extract for use as an immunosuppressive agent | 埃德蒙马赫基金会 | 2017-05-17 | — | — | CN | disclosed |
| US-9469596-B2 | Method for removing quaternary salt | ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20150031918-A1 | METHOD FOR REMOVING QUATERNARY SALT | ARAKAWA CHEMICAL INDUSTRIES, LTD. (JP) | 2015-01-29 | — | — | US | disclosed |
| US-20090060992-A1 | Preparation of magneto-vesicles with DOPE/DDAB layers | UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC., | 2009-03-05 | — | — | US | disclosed |
| US-20080107649-A1 | Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide | PEVION BIOTECH LTD. (CH) | 2008-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080107649-A1 | Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide | IAPP, APP, BACE1 | FABP3 1904/4885TERT 1306/4885PTPN1 1678/4885 |
| US-20230331806-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | RBM17, RTCB, RBM22 | FABP3 2872/4885TERT 134/4885PTPN1 1940/4885 |
| US-11802144-B2 | Circular RNA compositions and methods | RBM17, RTCB, RBM22 | FABP3 2872/4885TERT 134/4885PTPN1 1940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.